CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 26.48
  • -0.28-1.05%
Market Closed Jun 14 15:00 CST
4.24BMarket Cap25.46P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
1.48%314.2M
-33.32%230.2M
-34.46%344.8M
-67.52%182.31M
-42.53%309.63M
-42.37%345.25M
-47.60%526.09M
-47.26%561.36M
-48.59%538.78M
-55.51%599.08M
Transactional financial assets
0.22%341.64M
41.38%396.41M
441.20%271.32M
--371.09M
276.04%340.9M
3,001.66%280.37M
--50.13M
----
-57.43%90.65M
-95.02%9.04M
Notes receivable and accounts receivable
-1.88%253.29M
-4.61%263.96M
38.62%295.01M
33.18%307.79M
40.77%258.15M
18.26%276.72M
-28.69%212.81M
-25.44%231.11M
-9.45%183.38M
17.30%233.99M
-Accounts receivable
-1.88%253.29M
-4.61%263.96M
38.62%295.01M
33.18%307.79M
40.77%258.15M
18.26%276.72M
-27.10%212.81M
-20.41%231.11M
-0.96%183.38M
33.94%233.99M
Other receivables (including interest and dividends)
0.04%35.9M
28.22%35.56M
337.82%35.94M
397.23%38.19M
994.83%35.88M
339.47%27.73M
-56.49%8.21M
-61.67%7.68M
-84.82%3.28M
-83.50%6.31M
-Other receivable
----
----
----
397.23%38.19M
----
339.47%27.73M
----
-61.67%7.68M
----
-83.50%6.31M
Advance payment
14.59%28.88M
5.30%12.08M
-15.38%25.6M
8.76%29.67M
-32.32%25.2M
-48.06%11.47M
69.03%30.25M
211.13%27.28M
278.80%37.24M
360.86%22.09M
Inventories
16.51%48.04M
31.02%48.47M
20.98%44.48M
-0.30%40.13M
-5.91%41.23M
-21.33%36.99M
-25.74%36.77M
0.51%40.25M
20.86%43.82M
38.53%47.02M
Receivable financing
-6.62%11.55M
-4.10%18.86M
202.27%20.45M
259.22%16.34M
113.60%12.37M
89.34%19.67M
--6.77M
--4.55M
--5.79M
--10.39M
Other current assets
-73.97%56.33M
1,113.07%224.41M
3,265.50%218.32M
3,348.85%207.89M
960.29%216.37M
-7.07%18.5M
35.60%6.49M
-82.52%6.03M
516.71%20.41M
431.85%19.91M
Total current assets
-12.09%1.09B
20.97%1.23B
43.12%1.26B
35.88%1.19B
34.26%1.24B
7.27%1.02B
-37.03%877.52M
-40.56%878.26M
-39.83%923.36M
-47.58%947.83M
Non Current assets
Other equity investment
16.62%726.15M
29.86%684.31M
48.28%730.68M
54.13%789.03M
15.73%622.65M
-5.99%526.94M
-9.94%492.77M
-12.56%511.91M
-9.76%538.01M
-5.39%560.53M
Other non-current financial assets
-2.21%75.03M
-2.31%74.95M
--74.14M
--74.27M
--76.73M
--76.73M
----
----
----
----
Long-term equity investment
-30.05%48.92M
-29.45%49.58M
-62.76%68.38M
-57.90%69.27M
-59.31%69.93M
-48.10%70.28M
126.68%183.63M
102.10%164.54M
108.94%171.87M
100.75%135.42M
Fixed assets
----
----
----
-9.40%232.16M
----
-5.82%245.68M
----
-4.83%256.24M
----
-7.14%260.87M
Constru in process
----
----
----
35.72%185.12M
----
43.00%181.98M
----
133.90%136.41M
----
166.81%127.26M
Productive biological assets
----
----
----
----
----
----
----
----
-94.57%39.98K
-82.49%172.55K
Intangible assets
-0.99%852.73M
5.15%854.64M
5.25%856.66M
5.52%858.86M
5.79%861.27M
-0.30%812.75M
-0.27%813.9M
-0.33%813.91M
-0.81%814.1M
-0.37%815.17M
Development expenditure
119.62%162.72M
26.15%149.82M
-21.92%101.04M
-33.72%84.09M
-12.14%74.09M
46.49%118.76M
388.73%129.42M
--126.87M
--84.33M
--81.07M
Goodwill
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
-1.43%97.64M
-1.02%97.64M
Long deferred expense
-54.58%691.26K
-46.62%898.93K
18.52%1.11M
23.20%1.31M
26.84%1.52M
25.92%1.68M
7,082.21%933.69K
7,519.89%1.07M
7,899.22%1.2M
8,259.44%1.34M
Deferred tax assets
3,761.21%32.19M
2,870.53%32.27M
-85.14%1.23M
-89.92%878.49K
-89.95%833.77K
-87.88%1.09M
36.52%8.28M
37.15%8.72M
30.21%8.3M
27.12%8.96M
Usufruct assets
-80.00%2.08M
-66.67%4.16M
-52.47%6.24M
-44.55%8.32M
-38.39%10.4M
-33.46%12.48M
-36.36%13.13M
104.01%15.01M
--16.88M
--18.76M
Other non current assets
227.61%396.09M
-26.66%192.2M
-47.01%170.82M
-62.07%122.32M
-61.68%120.9M
-17.14%262.07M
305.37%322.38M
415.23%322.5M
638.86%315.55M
724.22%316.3M
Total non current assets
18.79%2.8B
5.93%2.55B
1.93%2.52B
2.79%2.52B
-3.30%2.36B
-0.64%2.41B
20.53%2.47B
20.91%2.45B
20.96%2.44B
22.56%2.42B
Total assets
8.15%3.89B
10.40%3.78B
12.72%3.78B
11.51%3.72B
7.01%3.6B
1.59%3.42B
-2.75%3.35B
-4.99%3.33B
-5.31%3.36B
-10.95%3.37B
Liabilities
Current liabilities
Short term loan
341.98%126.75M
--96.93M
--85.94M
--57.59M
--28.68M
----
----
----
----
----
Notes payable and accounts payable
281.02%88.43M
71.16%82.97M
21.08%41.27M
27.99%32.52M
21.56%23.21M
3.72%48.47M
-2.59%34.08M
-62.71%25.41M
-52.07%19.09M
-56.88%46.74M
-Accounts payable
281.02%88.43M
71.16%82.97M
21.08%41.27M
27.99%32.52M
21.56%23.21M
3.72%48.47M
-2.59%34.08M
-62.71%25.41M
-52.07%19.09M
-56.88%46.74M
Contract liabilities
62.31%4.32M
122.03%6.49M
1.05%1.43M
31.78%1.79M
21.89%2.66M
142.73%2.92M
128.67%1.41M
-34.60%1.36M
4.89%2.18M
-49.03%1.2M
Advance receipts
----
----
--36.23K
----
----
----
----
----
----
----
Salaries payable
13.96%17.44M
32.75%30.22M
20.78%21.07M
-5.31%16.61M
14.53%15.31M
-2.59%22.76M
0.15%17.44M
24.76%17.54M
-36.82%13.36M
16.40%23.37M
Taxs payable
-95.15%1.93M
-90.68%3.69M
33.27%37.77M
17.92%29.04M
40.97%39.92M
44.94%39.57M
47.51%28.34M
11.99%24.63M
15.71%28.32M
12.90%27.3M
Other payable (including interest and dividends)
69.43%89.84M
88.39%94M
10.10%53.87M
74.42%84.89M
8.98%53.02M
2.59%49.9M
9.89%48.93M
-87.97%48.67M
-88.26%48.65M
-88.29%48.63M
-Dividend payable
----
----
----
--31.3M
----
----
----
----
----
----
-Other payable
----
----
----
10.11%53.59M
----
2.59%49.9M
----
-87.97%48.67M
----
-88.29%48.63M
Non current liabilities due within one year
2.92%9.02M
4.12%9.07M
-20.45%6.18M
6.07%8.14M
15.46%8.76M
16.14%8.71M
-5.07%7.77M
173.94%7.68M
--7.59M
--7.5M
Other current liabilities
-29.51%38.65K
26.16%30.41K
-72.85%34.37K
-4.45%47.51K
-64.68%54.83K
10.88%24.11K
57.64%126.57K
-81.61%49.72K
-42.59%155.23K
-92.92%21.74K
Total current liabilities
96.82%337.77M
87.62%323.39M
79.28%247.59M
84.02%230.62M
43.78%171.61M
11.37%172.36M
10.46%138.1M
-76.85%125.32M
-77.49%119.36M
-73.99%154.77M
Current liabilities
Long term loan
-20.00%40.42M
--43.78M
--48.9M
--50.58M
--50.52M
----
----
----
----
----
Deferred tax liabilities
-15.39%37.85M
-6.22%27.78M
21.85%42.39M
34.77%50.96M
7.76%44.73M
-34.19%29.62M
-12.30%34.79M
-16.86%37.81M
-11.95%41.51M
-36.57%45.02M
Long term deferred income
-18.02%22.56M
-18.96%23.49M
-3.35%24.59M
-3.17%26.05M
-3.00%27.52M
-2.86%28.98M
-18.70%25.44M
-17.86%26.91M
-17.16%28.37M
-16.51%29.83M
Lease liabilities
----
----
----
-86.98%942.69K
-76.03%2.2M
-66.66%3.71M
-51.31%5.97M
61.96%7.24M
--9.19M
--11.12M
Total non current liabilities
-19.32%100.82M
52.54%95.05M
75.03%115.88M
78.63%128.54M
58.05%124.97M
-27.52%62.31M
-20.46%66.21M
-13.00%71.96M
-2.85%79.07M
-19.43%85.97M
Total liabilities
47.88%438.59M
78.31%418.44M
77.90%363.47M
82.05%359.16M
49.47%296.58M
-2.52%234.68M
-1.89%204.31M
-68.38%197.28M
-67.56%198.42M
-65.69%240.74M
Shareholders equity
Paid-in capital
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
Capital reserve funds
-3.24%960.29M
-3.77%955.01M
-4.25%948.54M
0.37%992.46M
0.55%992.46M
0.74%992.46M
0.08%990.63M
1.41%988.81M
1.41%986.99M
1.41%985.17M
Surplus reserve funds
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
Retained profit
7.20%2.01B
6.44%1.97B
6.21%1.97B
4.43%1.91B
1.83%1.88B
3.04%1.85B
3.87%1.85B
4.85%1.83B
4.33%1.84B
5.45%1.8B
Less:Treasury stock
-36.95%78.59M
-36.95%78.59M
-70.97%36.19M
0.00%124.64M
0.00%124.64M
0.00%124.64M
0.00%124.64M
23.65%124.64M
50.16%124.64M
--124.64M
Other composite income
-76.09%11.61M
19.20%-26.5M
119.68%12.93M
226.52%62.53M
278.10%48.54M
-304.51%-32.8M
-237.43%-65.69M
-478.02%-49.42M
-183.42%-27.25M
-104.96%-8.11M
Shareholders equity without minority interests
3.70%3.14B
4.58%3.06B
8.30%3.13B
6.81%3.08B
3.94%3.03B
1.29%2.93B
0.82%2.89B
0.42%2.89B
-0.39%2.92B
-6.16%2.89B
Minority interests
14.61%307.63M
14.47%302.44M
10.63%279.52M
10.06%274.7M
9.19%268.41M
9.27%264.22M
-31.19%252.67M
2,447.86%249.59M
2,409.30%245.82M
4,221.01%241.81M
Total shareholder equity
4.58%3.45B
5.40%3.36B
8.49%3.41B
7.07%3.36B
4.35%3.3B
1.90%3.19B
-2.81%3.15B
8.73%3.14B
7.64%3.16B
1.51%3.13B
Total liabilityies and equity
8.15%3.89B
10.40%3.78B
12.72%3.78B
11.51%3.72B
7.01%3.6B
1.59%3.42B
-2.75%3.35B
-4.99%3.33B
-5.31%3.36B
-10.95%3.37B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 1.48%314.2M-33.32%230.2M-34.46%344.8M-67.52%182.31M-42.53%309.63M-42.37%345.25M-47.60%526.09M-47.26%561.36M-48.59%538.78M-55.51%599.08M
Transactional financial assets 0.22%341.64M41.38%396.41M441.20%271.32M--371.09M276.04%340.9M3,001.66%280.37M--50.13M-----57.43%90.65M-95.02%9.04M
Notes receivable and accounts receivable -1.88%253.29M-4.61%263.96M38.62%295.01M33.18%307.79M40.77%258.15M18.26%276.72M-28.69%212.81M-25.44%231.11M-9.45%183.38M17.30%233.99M
-Accounts receivable -1.88%253.29M-4.61%263.96M38.62%295.01M33.18%307.79M40.77%258.15M18.26%276.72M-27.10%212.81M-20.41%231.11M-0.96%183.38M33.94%233.99M
Other receivables (including interest and dividends) 0.04%35.9M28.22%35.56M337.82%35.94M397.23%38.19M994.83%35.88M339.47%27.73M-56.49%8.21M-61.67%7.68M-84.82%3.28M-83.50%6.31M
-Other receivable ------------397.23%38.19M----339.47%27.73M-----61.67%7.68M-----83.50%6.31M
Advance payment 14.59%28.88M5.30%12.08M-15.38%25.6M8.76%29.67M-32.32%25.2M-48.06%11.47M69.03%30.25M211.13%27.28M278.80%37.24M360.86%22.09M
Inventories 16.51%48.04M31.02%48.47M20.98%44.48M-0.30%40.13M-5.91%41.23M-21.33%36.99M-25.74%36.77M0.51%40.25M20.86%43.82M38.53%47.02M
Receivable financing -6.62%11.55M-4.10%18.86M202.27%20.45M259.22%16.34M113.60%12.37M89.34%19.67M--6.77M--4.55M--5.79M--10.39M
Other current assets -73.97%56.33M1,113.07%224.41M3,265.50%218.32M3,348.85%207.89M960.29%216.37M-7.07%18.5M35.60%6.49M-82.52%6.03M516.71%20.41M431.85%19.91M
Total current assets -12.09%1.09B20.97%1.23B43.12%1.26B35.88%1.19B34.26%1.24B7.27%1.02B-37.03%877.52M-40.56%878.26M-39.83%923.36M-47.58%947.83M
Non Current assets
Other equity investment 16.62%726.15M29.86%684.31M48.28%730.68M54.13%789.03M15.73%622.65M-5.99%526.94M-9.94%492.77M-12.56%511.91M-9.76%538.01M-5.39%560.53M
Other non-current financial assets -2.21%75.03M-2.31%74.95M--74.14M--74.27M--76.73M--76.73M----------------
Long-term equity investment -30.05%48.92M-29.45%49.58M-62.76%68.38M-57.90%69.27M-59.31%69.93M-48.10%70.28M126.68%183.63M102.10%164.54M108.94%171.87M100.75%135.42M
Fixed assets -------------9.40%232.16M-----5.82%245.68M-----4.83%256.24M-----7.14%260.87M
Constru in process ------------35.72%185.12M----43.00%181.98M----133.90%136.41M----166.81%127.26M
Productive biological assets ---------------------------------94.57%39.98K-82.49%172.55K
Intangible assets -0.99%852.73M5.15%854.64M5.25%856.66M5.52%858.86M5.79%861.27M-0.30%812.75M-0.27%813.9M-0.33%813.91M-0.81%814.1M-0.37%815.17M
Development expenditure 119.62%162.72M26.15%149.82M-21.92%101.04M-33.72%84.09M-12.14%74.09M46.49%118.76M388.73%129.42M--126.87M--84.33M--81.07M
Goodwill 0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M-1.43%97.64M-1.02%97.64M
Long deferred expense -54.58%691.26K-46.62%898.93K18.52%1.11M23.20%1.31M26.84%1.52M25.92%1.68M7,082.21%933.69K7,519.89%1.07M7,899.22%1.2M8,259.44%1.34M
Deferred tax assets 3,761.21%32.19M2,870.53%32.27M-85.14%1.23M-89.92%878.49K-89.95%833.77K-87.88%1.09M36.52%8.28M37.15%8.72M30.21%8.3M27.12%8.96M
Usufruct assets -80.00%2.08M-66.67%4.16M-52.47%6.24M-44.55%8.32M-38.39%10.4M-33.46%12.48M-36.36%13.13M104.01%15.01M--16.88M--18.76M
Other non current assets 227.61%396.09M-26.66%192.2M-47.01%170.82M-62.07%122.32M-61.68%120.9M-17.14%262.07M305.37%322.38M415.23%322.5M638.86%315.55M724.22%316.3M
Total non current assets 18.79%2.8B5.93%2.55B1.93%2.52B2.79%2.52B-3.30%2.36B-0.64%2.41B20.53%2.47B20.91%2.45B20.96%2.44B22.56%2.42B
Total assets 8.15%3.89B10.40%3.78B12.72%3.78B11.51%3.72B7.01%3.6B1.59%3.42B-2.75%3.35B-4.99%3.33B-5.31%3.36B-10.95%3.37B
Liabilities
Current liabilities
Short term loan 341.98%126.75M--96.93M--85.94M--57.59M--28.68M--------------------
Notes payable and accounts payable 281.02%88.43M71.16%82.97M21.08%41.27M27.99%32.52M21.56%23.21M3.72%48.47M-2.59%34.08M-62.71%25.41M-52.07%19.09M-56.88%46.74M
-Accounts payable 281.02%88.43M71.16%82.97M21.08%41.27M27.99%32.52M21.56%23.21M3.72%48.47M-2.59%34.08M-62.71%25.41M-52.07%19.09M-56.88%46.74M
Contract liabilities 62.31%4.32M122.03%6.49M1.05%1.43M31.78%1.79M21.89%2.66M142.73%2.92M128.67%1.41M-34.60%1.36M4.89%2.18M-49.03%1.2M
Advance receipts ----------36.23K----------------------------
Salaries payable 13.96%17.44M32.75%30.22M20.78%21.07M-5.31%16.61M14.53%15.31M-2.59%22.76M0.15%17.44M24.76%17.54M-36.82%13.36M16.40%23.37M
Taxs payable -95.15%1.93M-90.68%3.69M33.27%37.77M17.92%29.04M40.97%39.92M44.94%39.57M47.51%28.34M11.99%24.63M15.71%28.32M12.90%27.3M
Other payable (including interest and dividends) 69.43%89.84M88.39%94M10.10%53.87M74.42%84.89M8.98%53.02M2.59%49.9M9.89%48.93M-87.97%48.67M-88.26%48.65M-88.29%48.63M
-Dividend payable --------------31.3M------------------------
-Other payable ------------10.11%53.59M----2.59%49.9M-----87.97%48.67M-----88.29%48.63M
Non current liabilities due within one year 2.92%9.02M4.12%9.07M-20.45%6.18M6.07%8.14M15.46%8.76M16.14%8.71M-5.07%7.77M173.94%7.68M--7.59M--7.5M
Other current liabilities -29.51%38.65K26.16%30.41K-72.85%34.37K-4.45%47.51K-64.68%54.83K10.88%24.11K57.64%126.57K-81.61%49.72K-42.59%155.23K-92.92%21.74K
Total current liabilities 96.82%337.77M87.62%323.39M79.28%247.59M84.02%230.62M43.78%171.61M11.37%172.36M10.46%138.1M-76.85%125.32M-77.49%119.36M-73.99%154.77M
Current liabilities
Long term loan -20.00%40.42M--43.78M--48.9M--50.58M--50.52M--------------------
Deferred tax liabilities -15.39%37.85M-6.22%27.78M21.85%42.39M34.77%50.96M7.76%44.73M-34.19%29.62M-12.30%34.79M-16.86%37.81M-11.95%41.51M-36.57%45.02M
Long term deferred income -18.02%22.56M-18.96%23.49M-3.35%24.59M-3.17%26.05M-3.00%27.52M-2.86%28.98M-18.70%25.44M-17.86%26.91M-17.16%28.37M-16.51%29.83M
Lease liabilities -------------86.98%942.69K-76.03%2.2M-66.66%3.71M-51.31%5.97M61.96%7.24M--9.19M--11.12M
Total non current liabilities -19.32%100.82M52.54%95.05M75.03%115.88M78.63%128.54M58.05%124.97M-27.52%62.31M-20.46%66.21M-13.00%71.96M-2.85%79.07M-19.43%85.97M
Total liabilities 47.88%438.59M78.31%418.44M77.90%363.47M82.05%359.16M49.47%296.58M-2.52%234.68M-1.89%204.31M-68.38%197.28M-67.56%198.42M-65.69%240.74M
Shareholders equity
Paid-in capital 0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M
Capital reserve funds -3.24%960.29M-3.77%955.01M-4.25%948.54M0.37%992.46M0.55%992.46M0.74%992.46M0.08%990.63M1.41%988.81M1.41%986.99M1.41%985.17M
Surplus reserve funds 0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M
Retained profit 7.20%2.01B6.44%1.97B6.21%1.97B4.43%1.91B1.83%1.88B3.04%1.85B3.87%1.85B4.85%1.83B4.33%1.84B5.45%1.8B
Less:Treasury stock -36.95%78.59M-36.95%78.59M-70.97%36.19M0.00%124.64M0.00%124.64M0.00%124.64M0.00%124.64M23.65%124.64M50.16%124.64M--124.64M
Other composite income -76.09%11.61M19.20%-26.5M119.68%12.93M226.52%62.53M278.10%48.54M-304.51%-32.8M-237.43%-65.69M-478.02%-49.42M-183.42%-27.25M-104.96%-8.11M
Shareholders equity without minority interests 3.70%3.14B4.58%3.06B8.30%3.13B6.81%3.08B3.94%3.03B1.29%2.93B0.82%2.89B0.42%2.89B-0.39%2.92B-6.16%2.89B
Minority interests 14.61%307.63M14.47%302.44M10.63%279.52M10.06%274.7M9.19%268.41M9.27%264.22M-31.19%252.67M2,447.86%249.59M2,409.30%245.82M4,221.01%241.81M
Total shareholder equity 4.58%3.45B5.40%3.36B8.49%3.41B7.07%3.36B4.35%3.3B1.90%3.19B-2.81%3.15B8.73%3.14B7.64%3.16B1.51%3.13B
Total liabilityies and equity 8.15%3.89B10.40%3.78B12.72%3.78B11.51%3.72B7.01%3.6B1.59%3.42B-2.75%3.35B-4.99%3.33B-5.31%3.36B-10.95%3.37B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg